MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202647105785 A) filed by Ecole Polytechnique Federale De Lausanne Epfl on September 02, 2026, for Engineered Type 2 Cytokine Signalling To Improve Car-T Cell Effector Functions.
Inventors include Tang, Li; Zhao, Yang; Enbar, Tom; and Feng, Bing.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The invention relates to chimeric antigen receptor constructs and their use for treatments and therapies. Further disclosed are methods of treating and/or preventing a disease, such as e.g. a cancer, an infectious disease, an inflammatory or inflammation-induced disease, a chronic disease or an autoimmune disease.
Disclaimer: Curated by HT Syndication.
